Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Impending fracture risk and prophylactic fixation

Musculoskeletal medicine and orthopaedics · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

New deformity, a crack during transfer or sudden inability to use a tumour-bearing limb indicates completed fracture: stop movement, splint, document distal neurovascular status and escalate urgently. Until stability is established, use protected or non-weight bearing for functional pain through a proximal femur or other critical cortex. Neurological spinal symptoms follow the separate MSCC emergency pathway. Do not perform empirical fixation before specialist diagnostic review of a solitary or unbiopsied lesion.

Synopsis

Detect a metastatic long bone approaching mechanical failure, integrate symptoms and cross-sectional cortical assessment with decision tools and stabilise electively before fracture when benefit outweighs operative burden.

  • Functional pain during weight bearing or transfer is the most important bedside warning of impending long-bone failure and should trigger immediate load protection.
  • First-line imaging is full-length radiography in two planes; CT is the preferred structural adjunct for circumferential cortical loss and operative geometry.
  • Mirels scores site, pain, lytic character and lesion size from one to three each; a total of nine or more historically supports fixation consideration.
  • Use Mirels as decision support, not an automatic rule: intermediate scores, lesion geometry, CT cortex, tumour response, survival and patient goals require specialist judgement.
  • MRI answers occult fracture and marrow or soft-tissue extent; it does not measure everyday torsional strength by itself.
  • Protect weight bearing while the plan is made, because radiotherapy and antiresorptive treatment cannot immediately rebuild critically absent cortex.
  • Prophylactic fixation generally permits easier surgery and earlier function than reconstruction after a complete fracture when risk and prognosis justify intervention.
  • Choose nail, plate, cement augmentation or endoprosthetic replacement to bypass the entire mechanically relevant lesion and remain durable without depending on union.

Key red flags

Pain produced by standing, rising from a chair or rotating the limb is a mechanical warning even when resting pain is controlled.

A peritrochanteric lytic lesion with extensive circumferential cortical loss can fracture during an ordinary transfer and needs urgent protection.

Increasing pain after radiotherapy may mean progression or microfracture; tumour treatment does not certify immediate structural recovery.

A solitary lesion, unusual matrix or absent confirmed primary requires staging and tumour-aware biopsy before a prophylactic implant is passed through it.

A renal-cell or thyroid metastasis can bleed substantially during fixation and should prompt embolisation and blood-loss planning.

New skin compromise, distal sensory or vascular change or rapidly enlarging swelling requires same-day surgical reassessment rather than score calculation.

Investigation priorities

01
First-line full-length radiographsFirst stepFirst line

Establish lesion phenotype, longitudinal extent, cortical destruction, fracture and relation to joints or existing implants.

Management branches

Immediate protectionStop the lesion completing

Functional pain or imaging indicates a high-load cortex may fail during ordinary activity.

  1. Prescribe explicit protected or non-weight bearing and provide a safe aid before further transfers.
  2. Obtain full-length radiographs and urgent CT, adding MRI for occult fracture or uncertain extent.
  3. Document skin and distal neurovascular findings and repeat them after any sudden symptom change.
  4. Escalate loss of alignment or a crack as completed fracture rather than continuing score-based observation.

Key medicines

Paracetamol during protected mobilisationUse 500 to 1,000 mg orally when required with at least four hours between doses, limiting total intake to 4 g daily and reducing the ceiling in low weight, malnutrition or liver disease.Check all combination products and alcohol exposure; pain masking must never be used as evidence that a structurally weak limb can bear full weight.
Low-molecular-weight heparin when VTE assessment supports itUse the locally approved prophylactic regimen according to body weight, renal function, platelet history, bleeding risk and planned neuraxial or operative timing.Coordinate withholding and restarting around biopsy, embolisation and surgery; monitor bleeding and platelets as indicated and do not prescribe a generic dose in severe renal impairment.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Metastatic Fracture-Risk Decision ReviewMirels limitations, CT-based methods and integrated clinical decisions.
  • Prophylactic Femoral Nailing ReviewIndications, imaging, embolisation and reconstructive practice.
  • Long-Bone Metastasis Management ReviewMechanical protection, fixation and radiotherapy sequencing.
  • Original Mirels Scoring StudyFour-component historical fracture-risk score and proposed threshold.
  • NICE NG89 VTE PreventionIndividual thrombosis and bleeding assessment around immobility and surgery.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom